*Falsey AR et al. (2001) Response of C-Reactive Protein and Serum Amyloid A to Influenza A Infection in Older Adults. J Infect Dis. 183(7):995-999*Horan JT et al. (2001) Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections.Thromb Haemost. Feb;85(2):245-249*Hasegawa G et al. (2005) Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.Acta Diabetologica 42(2):104-109*Yoshida T et al. (2006) Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation.Diabetologia 49:3094-3099*Nagaoka S et al. (2007) Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver International 27:1091-1097*Kajiyama S et al. (2008) Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.Nutrition Research 28(3):137-43*Kotani K et al. (2008) The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population.Clin Chem Lab Med. 46(10):1434-1437*Lee JW et al. (2009) Cohort Profile: The biopsychosocial religion and health study (BRHS).Int J Epidemiol. 38(6):1470-1478*Ghosh A et al. (2010) Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana.Am J Clin Nutr.92:928-939*Kotani Ket al. (2010) Association between coffee consumption and the estimated glomerular filtration rate in the general Japanese population: preliminary data regarding C-reactive protein concentrations. Clin. Chem. Lab Med. 48(12):1773-1776* Ling XB et al. (2010) Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. Proteomics. 2010 Dec;10(24):4415-30 *Nakano K et al. (2010) Effect of pioglitazone on various parameters of insulin resistance including lipoprotein subclass according to particle size by a gel-permeation high-performance liquid chromatography in newly diagnosed patients with type 2 diabetes.Endocrine Journal. 57(5):423-430*Ross ML et al. (2010) Cytokine responses to carbohydrate ingestion during recovery from exercise-induced muscle injury. J Interferon Cytokine Res. 30(5):329-337*Singh KV et al. (2010) 3D nanogap interdigitated electrode array biosensors.Anal Bioanal Chem. 397(4):1493-1502*Kotani K et al. (2011) Serum amyloid A low-density lipoprotien levels and smoking status in obese Japanese patients. J Int Med Res. 2011;39(5):1917-22*Morand C et al. (2011) Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers.Am. J. Clin Nutr. 93(1):73-80*Alkhateeb AA et al. (2012) Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy. PLoS One. 7(12):e51379 *Keicho N et al. (2012) Circulating levels of adiponectin, leptin, fetuin-A and retinol-binding protein in patients with tuberculosis: markers of metabolism and inflammation. PLoS One. 7(6):e38703. doi: 10.1371/journal.pone.0038703. Epub 2012 Jun 7*Kotani K and Sakane N. (2012) White Blood Cells, Neutrophils, and Reactive Oxygen Metabolites among Asymptomatic Subjects. International Journal of Preventive Medicine 3(6):428-431*Kotani K and Taniguchi N. (2012) Correlation Between High-sensitivity C-reactive Protein and Reactive Oxygen Metabolites During A One-year Period Among Asymptomatic Subjects. J Clin Med Res. 4(1):52-55 *Kim CH et al. (2013) CRP detection from serum for chip-based point-of-care testing system. Biosens Bioelectron. 41:322-7* Yoshida T et al. (2006) Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product (AGE)-induced C-reactive protein expression in hepatoma cells by suppressing Rac-1 activation. FEBS Letters 580:2788-2796* Lai HY et al. (2014) Association between inflammatory markers and frailty in institutionalized older men. Maturitas 79(3):329-333* Elci E et al. (2017) Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries. Gynecol Endocrinol. 33(1):43-47. Epub 2016 Jul 16.